Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / genmab abbvie win fda nod for r r follicular lymphom

GMAB - Genmab AbbVie win FDA nod for r/r follicular lymphoma therapy

Genmab A/S

2024-06-27 05:34:44 ET

Genmab ( GMAB ) and partner AbbVie ( NYSE: ABBV ) have received U.S. FDA approval for their monoclonal antibody Epkinly (epcoritamab-bysp) for the treatment of adults with relapsed or refractory follicular lymphoma....

For further details see:

Genmab, AbbVie win FDA nod for r/r follicular lymphoma therapy
Stock Information
Company Name: Genmab A/S
Stock Symbol: GMAB
Market: NYSE
Website: genmab.com
Menu
GMAB GMAB Quote GMAB Short GMAB News GMAB Articles GMAB Message Board
Get GMAB Alerts

News, Short Squeeze, Breakout and More Instantly...